Compare Revvity Inc (RVTY) vs Twist Bioscience Corp (TWST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Revvity Inc vs Twist Bioscience Corp — how do they compare? Revvity Inc trades at $110.7 (market cap $11.87B), while Twist Bioscience Corp trades at $88.31 (market cap $5.45B). The key difference: Revvity Inc is far larger — about 2.2× Twist Bioscience Corp's market cap, and Revvity Inc pays a 0.26% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals.
| RVTY | TWST | |
|---|---|---|
Market Cap | $11.87B | $5.45B |
Sector | Technology | Health |
52-Week High | $117.75 | $102.88 |
52-Week Low | $82.26 | $24.16 |
Enterprise Value | $14.36B | $5.37B |
Dividend Yield | 0.26% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Revvity Inc
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →About Twist Bioscience Corp
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →
